The outcome
On average, people taking GLP-1 Treatments, Semaglutide or Tirzepatide eat about 30% less food than they would otherwise
These pathways are involved in appetite, fullness, digestion, glucose regulation, and energy balance
Retatrutide can plausibly cause heartburn-type symptoms because its GLP-1 receptor activity slows gastric emptying, increasing intra-gastric pressure and the likelihood of acid reflux
Expect similar gastrointestinal effects across these drugs but with varying intensities and speeds of weight change, such as: Nausea Diarrhea Constipation Which matters more to you: Appetite suppression Speed of change How tolerable are the side effects Can Tirzepatide Cause Blood Clots
What "not FDA-approved" actually means for compounded medications When a compounded medication is described as "not FDA-approved," that means the FDA hasn't reviewed that specific compounded formulation for safety, effectiveness, or manufacturing quality before dispensing